Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview

1909studies shown

Showing 1,333-1,344 of 1,909

CompletedNCT01284517

Lurasidone HCI - A 6-week Phase 3 Study of people with Bipolar I Depression

This study is completed in the United States, in Canada, in Colombia, .... It focuses on depression.

Multiple locations, including Costa Mesa

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, Canada, Colombia, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Dothan

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 10 Years to 17 Years

Countries: United States, France, Bulgaria, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT00382915

Measuring Smoking Behavior in People With Schizophrenia and Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In New Brunswick

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDeviceFrom 18 Years to 75 Years

Countries: United States
Sponsor: University of Medicine and Dentistry of New Jersey
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT03630822

Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolarity type I or Schizoaffective Disorder

This study is completed in France. It focuses on schizophrenia.

In Marseille

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaBehavioralOver 18 Years

Countries: France
Sponsor: Assistance Publique Hopitaux De Marseille
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT01929681

Multiple Treatment Study Using Low Field Magnetic Stimulation for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Belmont

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDeviceFrom 21 Years to 65 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Bipolarity, Depression

View study

CompletedNCT03402152

NRX101 Glx Biomarker Validation Study

This summary needs review. Please check the official study record and contact the research team for details.

In New York

Why is this study shown?

This study includes Bipolarity among several conditions.

Suicidality, Bipolarity, ...DrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: NeuroRx, Inc.
Condition: Suicidality, Bipolarity, ...

View study

CompletedNCT02287259

Olanzapine Versus Lithium in the Treatment of Acute Depression in people with Bipolar II or Bipolar Not Otherwise Specified(OL Study)

This study is completed in Japan. It focuses on depression.

In Chiba

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: Japan
Sponsor: Tadashi Hasegawa
Condition: Bipolarity, Depression

View study

CompletedNCT00485771

Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Lafayette

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Eli Lilly and Company
Condition: Bipolarity, Depression

View study

WithdrawnNCT00204503

Depakote ER in people with Bipolar I or II Depression and Alcohol Abuse or Dependence

This study was withdrawn in the United States. It focuses on depression.

In Galveston

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: The University of Texas Medical Branch, Galveston
Condition: Bipolarity, Depression

View study

CompletedNCT00237666

Study of Geodon in Non-Rapid Cycling Bipolar II people with Major Depression

This study is completed in the United States. It is testing geodon for depression.

Multiple locations, including New York

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugOver 18 Years

Countries: United States
Sponsor: The Medical Research Network
Condition: Bipolarity, Depression

View study

CompletedNCT06053346

Partners in Wellness: Evaluation of a Pay for Performance Program for High-Utilizers of Mental Health Services

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

Why is this study shown?

This study includes Bipolarity among several conditions.

Addiction, Bipolarity, ...BehavioralFrom 18 Years to 65 Years

Countries
Sponsor: Stanford University
Condition: Addiction, Bipolarity, ...

View study

CompletedNCT00422123

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

This study is completed in the United States. It focuses on Bipolarity.

Multiple locations, including Phoenix

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Schizophrenia, ...DrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AstraZeneca
Condition: Bipolarity, Schizophrenia, ...

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.